Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-24 @ 4:37 PM
NCT ID:
NCT05441566
Eligibility Criteria:
Inclusion Criteria:
1. Patients with stage I-II operable NSCLC in AJCC TNM stage (8th edition) confirmed by clinical pathological staging;
2. The physical condition and organ function allow surgery and postoperative adjuvant therapy；
3. At the time of signing the informed consent form, the age is equal to or greater than 18 years old;
4. Tumor histology or cytology confirmed NSCLC;
5. Never received any surgery, radiotherapy, chemotherapy or molecular targeted anti-tumor therapy;
6. Eastern Cooperative Oncology Group performance status score (ECOG PS) is 0 \~ 1 points;
7. Patients agree and have the ability to follow the planned study visits, treatment plan, laboratory tests and other research steps;
8. Expected survival time ≥ 6 months.
Exclusion Criteria:
1. Patients with other malignant tumors;
2. Patients with inoperable clinical evaluation;
3. Patients with other serious diseases that may affect follow-up and significant short-term survival;
4. Patients who have received previous anti-tumor treatment such as surgery, chemotherapy, targeted or immunotherapy;
5. Eastern Cooperative Oncology Group performance status score (ECOG PS) \> 2 points;
6. Patients with clinically clear active infection, including but not limited to pneumonia;
7. Any other condition and social/psychological problems, etc., judged by the investigator that the patient is not suitable for participating in this study; can not accept the use of contrast-enhanced magnetic resonance imaging (MRI) or contrast-enhanced computed tomography (CT) for clinical follow-up;
8. Other researchers think it is not suitable;
9. or can not comply with the study protocol.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT05441566
Study Brief:
Protocol Section:
NCT05441566